SynapDx Licenses Technology from Children's Hospital Boston to Develop Array-based Autism Tests
May 03, 2011
SynapDx Licenses Technology from Children's Hospital Boston to Develop Array-based Autism Tests
The Southborough, Mass.-based startup is using gene-expression arrays to distinguish children with autism from those with other kinds of developmental disorders.
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- Autism-Associated Variants Uncovered by Population Diagnostics, SickKids Team Could Yield Dx Tests
December 11, 2012 / BioArray News - Major Autism Center to Offer Lineagen's FirstStepDx ASD Array Test to Patients, Families
December 4, 2012 / BioArray News - Dx Firms GenMark, Nanosphere, CombiMatrix Attribute Q1 Revenue Growth to Sales Efforts
May 14, 2013 / BioArray News - Affy Files CytoScan with FDA, Plans 'Aggressive' Marketing Campaign to Grow Cyto Business
February 19, 2013 / BioArray News - After 'Pivotal' 2012, Affy Looks to CytoScan, Axiom Genotyping Products to Drive Future Growth
February 5, 2013 / BioArray News